The following table provides the prescribing information for Amgen Canada’s major approved products. Due to differences in Global labelling, this information is intended for residents of Canada only. Canadian regulations limit the amount and scope of information we can provide on our prescription drugs. If you require more information you should consult a qualified health professional.

Brand Name		Product Monograph
Aranesp®
Enbrel®   Dear HCP Letter            Public_Communication
Neulasta®
Neupogen®
NPlate™
Sensipar®
Vectibix™

To view PDF Files, you must have Acrobat Reader.